BCHE and Alzheimer disease: By inhibiting cholinesterase activity, it slows down the decomposition of acetylcholine in the synaptic cleft of neurons, thereby increasing the content of acetylcholine and improving the clinical symptoms of AD patients (Zhang and Gordon, 2018).